Breast cancer research and development: hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Seventh Congress, first session, special hearing, May 9, 2001, Washington, DC.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Statement of James S Marks M D M P H Director National Center
Opening statement of Senator Tom Harkin
Statement of Peri Gilpin actress and breast cancer advocate member
2 other sections not shown
Other editions - View all
advocacy agents American Cancer Society Arlen Specter biomarkers breast and cervical Breast Cancer Coalition breast cancer research breast cancer survivor breast cancer treatment Brinker budget Cancer Early Detection cancer patients CDC's Centers for Disease cervical cancer Cervical Cancer Early Chairman Specter clinical trials commitment Committee continue cure diagnosed with breast discovery Disease Control drugs Early Detection Program EDRN efforts eradicate this disease estrogen receptor Federal fight fiscal year 2001 funding genes Herceptin identify important improved increase initiative Iowa issue Klausner Komen Foundation Leffall mammogram mammography mastectomy Medicaid medically underserved million molecular targets National Breast Cancer National Cancer Institute NBCCEDP NCI's outreach percent Peri Gilpin PREPARED STATEMENT questions raloxifene rates receptor risk Seffrin Senator Harkin Senator Murray Senator Specter stem cells studies subcommittee tamoxifen technologies tests Thank therapies tion tumor Visco women diagnosed